Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 9—September 2020

Costs Associated with Nontuberculous Mycobacteria Infection, Ontario, Canada, 2001–2012

Lauren C. RamsayComments to Author , Emily Shing, John Wang, Theodore K. Marras, Jeffrey C. Kwong, Sarah K. Brode, Frances B. Jamieson, and Beate Sander
Author affiliations: University Health Network, Toronto, Ontario, Canada (L.C. Ramsay, T.K. Marras, J.C. Kwong, S.K. Brode, B. Sander); University of Toronto, Toronto (L.C. Ramsay, T.K. Marras, J.C. Kwong, S.K. Brode, F.B. Jamieson, B. Sander); Public Health Ontario, Toronto (E. Shing, J. Wang, J.C. Kwong, F.B. Jamieson, B. Sander); ICES, Toronto (J. Wang, J.C. Kwong, S.K. Brode, B. Sander); West Park Healthcare Centre, Toronto (S.K. Brode)

Main Article

Table 5

Sensitivity analysis 10-d mean attributable costs by phase for nontuberculous mycobacterial pulmonary disease and nontuberculous mycobacterial pulmonary isolation, Ontario, Canada, 2001–2012*

Phase (no. patients) Cost, CAD
Exposed persons Unexposed persons Attributable (95% CI)
Nontuberculous mycobacterial pulmonary disease
Mean cost by phase
Initial infection (6,187) 1,189 238 951 (875–1,027)
Subsequent care (6,187) 653 227 428 (370–485)
Continuous care (5,907) 493 304 190 (153–227)
Before death (2,204)
1,479 (1,176–1,781)
Nontuberculous mycobacterial pulmonary isolation
Mean cost by phase
Initial infection (7,693) 807 193 614 (570–659)
Subsequent care (7,693) 412 192 220 (189–253)
Continuous care (7,471) 370 261 108 (85–130)
Before death (1,963) 4,692 3,843 850 (589–1,110)

*Analysis excluded excluding persons with a history of lung cancer or cystic fibrosis. CAD, 2018 Canadian dollars. In 2018, $1 CAD in 2018 = $0.77 US dollars.

Main Article

Page created: July 10, 2020
Page updated: August 18, 2020
Page reviewed: August 18, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.